Unlock Innovation.
Unleash Potential.

Ajinomoto Bio-Pharma Services is a global network of specialized CDMOs and enabling technologies, advancing manufacturing and development solutions that enable our partners to bring therapies to patients around the world.

Our CDMO Services

Find the development and manufacturing expertise your program needs across small molecules, oligonucleotides, peptides, gene therapy, proteins, and bioconjugates.

Small Molecule

Small Molecule Manufacturing

APIs and intermediates, including specialized solutions for complex chemistry.

Oligonucleotide

Oligonucleotide Manufacturing

Solid-phase synthesis and proprietary AJIPHASE™ liquid-phase technology.

Peptide

Peptide Manufacturing

Complex and high-volume peptides, including GLP-1 analogs.

AAV

Gene Therapy Manufacturing

AAV development and GMP manufacturing through Forge Biologics.

Protein

Protein Manufacturing

Recombinant protein production through secretion for simplified purification and higher purity.

ADC

ADC & Bioconjugation Services

Next-generation site-specific conjugation and linker technologies for ADCs and bioconjugates.

Advanced Manufacturing

Improving the Health of Humankind

Our mission is to help improve the health of humankind by advancing manufacturing and development solutions that enable our partners to bring therapies to patients around the world.

How we deliver matters just as much as what we deliver. Across our global network, our commitment to quality, operational excellence, sustainability, and dependable partnership gives our partners confidence at every stage.

Scientific Innovation

Building on a Legacy of Scientific Innovation

For more than a century, the Ajinomoto Group has pioneered science to solve complex challenges and create new possibilities for people, society, and the planet.

That legacy of scientific rigor, R&D excellence, and continuous innovation shapes how we approach biopharma development and manufacturing today, from advancing processes for increasingly complex medicines to creating proprietary technologies such as AJIPHASE™, AJICAP™, and CORYNEX™ that give biopharma innovators new ways to advance their science.

Specialized Expertise with Global Scale

50+

Years of CDMO Experience

2,000+

Employees Worldwide

4

Countries of Operation

7

Specialized Facilities

Put the Right Capabilities
Behind Your Program

See how our specialists can support your program.